Author

Bastiaan J. Viergever

University Medical Center UtrechtORCID 0000-0001-7281-5872Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:organoid / primary culture· 1

Frequent Co-Authors

Onno KranenburgiD· 2 shared Alba ZuidemaiD· 1 shared André VerheemiD· 1 shared Balázs GyőrffyiD· 1 shared Cynthia Lisanne FrederiksiD· 1 shared Enric MocholíiD· 1 shared Kyah van MegeseniD· 1 shared Levi Nijland· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Onno KranenburgORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyCancer LettersPeer-reviewedJun 11, 2026

Site-dependent Treg cell transcriptional reprograming in a metastatic colorectal cancer model holds prognostic significance

Sonia Aristín Revilla, André Verheem, Cynthia Lisanne Frederiks…·Paul James Coffer

The paper identifies location-specific transcriptional differences in tumor-infiltrating Treg cells across CRC metastases and links these to poor patient prognosis.

DOI 10.1016/j.canlet.2026.218656

mousebulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintAug 29, 2025

ATR inhibitors synergize with mitomycin C to enhance cytotoxicity in patient-derived non-muscle invasive bladder cancer organoids

Alba Zuidema, Levi Nijland, Mette Marit Vosjan…·Richard Paul Meijer

This study shows that combining ATR inhibitors with mitomycin C significantly reduces viability of NMIBC organoids compared to chemotherapy or ATR inhibitors alone.

DOI 10.1101/2025.08.29.673024

humanorganoid / primary culture

𝕏 PostBluesky